{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T03:54:05Z","timestamp":1778990045072,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005800","name":"Eye Bank Association of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005800","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30EY014801"],"award-info":[{"award-number":["P30EY014801"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016850","name":"Beauty of Sight Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY024485"],"award-info":[{"award-number":["R01EY024485"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY030283"],"award-info":[{"award-number":["R01EY030283"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017017","name":"Hamill Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017017","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001315","name":"Sid W. Richardson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001315","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.jtos.2022.04.007","type":"journal-article","created":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T12:23:03Z","timestamp":1651062183000},"page":"40-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["A multicenter report of the use of plasma rich in growth factors (PRGF) for the treatment of patients with ocular surface diseases in North America"],"prefix":"10.1016","volume":"25","author":[{"given":"Matias","family":"Soifer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arianna","family":"Tovar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hazem M.","family":"Mousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sowmya","family":"Yennam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso L.","family":"Sabater","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen C.","family":"Pflugfelder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5872-5950","authenticated-orcid":false,"given":"Victor L.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtos.2022.04.007_bib1","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1001\/archopht.1975.01010020815015","article-title":"Clinical experience with a mobile ocular perfusion pump","volume":"93","author":"Ralph","year":"1975","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jtos.2022.04.007_bib2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/art.1780270415","article-title":"Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca","volume":"27","author":"Fox","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jtos.2022.04.007_bib3","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/OPX.0000000000001063","article-title":"Corneal nerve morphology, sensitivity, and tear neuropeptides in contact lens wear","volume":"94","author":"Golebiowski","year":"2017","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.jtos.2022.04.007_bib4","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1167\/iovs.16-21372","article-title":"Corneal epithelium-derived neurotrophic factors promote nerve regeneration","volume":"58","author":"Di","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2022.04.007_bib5","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.transci.2018.06.001","article-title":"Comparison of growth factor and interleukin content of adult peripheral blood and cord blood serum eye drops for cornea and ocular surface diseases","volume":"57","author":"Buzzi","year":"2018","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.jtos.2022.04.007_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s004170050034","article-title":"The effects of growth factors and conditioned media on the proliferation of human corneal epithelial cells and keratocytes","volume":"236","author":"Pancholi","year":"1998","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jtos.2022.04.007_bib7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S1350-9462(99)00007-5","article-title":"Growth factors: importance in wound healing and maintenance of transparency of the cornea","volume":"19","author":"Imanishi","year":"2000","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.jtos.2022.04.007_bib8","article-title":"Use of acellular umbilical cord-derived tissues in corneal and ocular surface diseases","volume":"8","author":"Tovar","year":"2021","journal-title":"Medicine"},{"key":"10.1016\/j.jtos.2022.04.007_bib9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s40135-021-00266-0","article-title":"Autologous blood products: when, where, and how?","volume":"9","author":"Tovar","year":"2021","journal-title":"Curr. Ophthalmol."},{"key":"10.1016\/j.jtos.2022.04.007_bib10","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.transci.2017.07.023","article-title":"Blood derived eye drops for the treatment of cornea and ocular surface diseases","volume":"56","author":"Giannaccare","year":"2017","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.jtos.2022.04.007_bib11","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1902\/jop.2012.120292","article-title":"Plasma rich in growth factors promotes bone tissue regeneration by stimulating proliferation, migration, and autocrine secretion in primary human osteoblasts","volume":"84","author":"Anitua","year":"2013","journal-title":"J Periodontol"},{"key":"10.1016\/j.jtos.2022.04.007_bib12","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/ICO.0b013e3181a81820","article-title":"Plasma rich in growth factors as a therapeutic agent for persistent corneal epithelial defects","volume":"29","author":"Lopez-Plandolit","year":"2010","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2022.04.007_bib13","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1089\/jop.2016.0166","article-title":"The effect of immunologically safe plasma rich in growth factor eye drops in patients with sjogren syndrome","volume":"33","author":"Sanchez-Avila","year":"2017","journal-title":"J Ocul Pharmacol Therapeut"},{"key":"10.1016\/j.jtos.2022.04.007_bib14","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1097\/ICO.0b013e31820d86d6","article-title":"Efficacy of plasma rich in growth factors for the treatment of dry eye","volume":"30","author":"Lopez-Plandolit","year":"2011","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2022.04.007_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000439280","article-title":"Autologous plasma rich in growth factors eyedrops in refractory cases of ocular surface disorders","volume":"55","author":"Merayo-Lloves","year":"2015","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.jtos.2022.04.007_bib16","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000444496","article-title":"Safety and efficacy of autologous plasma rich in growth factors eye drops for the treatment of evaporative dry eye","volume":"56","author":"Merayo-Lloves","year":"2016","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.jtos.2022.04.007_bib17","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s10792-017-0582-7","article-title":"Treatment of patients with neurotrophic keratitis stages 2 and 3 with plasma rich in growth factors (PRGF-Endoret) eye-drops","volume":"38","author":"Sanchez-Avila","year":"2018","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.jtos.2022.04.007_bib18","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1177\/1120672118818943","article-title":"Plasma rich in growth factors for the treatment of dry eye from patients with graft versus host diseases","volume":"30","author":"Sanchez-Avila","year":"2020","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jtos.2022.04.007_bib19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.exer.2016.08.012","article-title":"PRGF exerts more potent proliferative and anti-inflammatory effects than autologous serum on a cell culture inflammatory model","volume":"151","author":"Anitua","year":"2016","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2022.04.007_bib20","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.2147\/OPTH.S252253","article-title":"Plasma rich in growth factors for the treatment of cicatrizing conjunctivitis","volume":"14","author":"de la Sen-Corcuera","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2022.04.007_bib21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000487951","article-title":"Plasma rich in growth factors for the treatment of dry eye after LASIK surgery","volume":"60","author":"Sanchez-Avila","year":"2018","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.jtos.2022.04.007_bib22","first-page":"97","article-title":"Plasma rich in growth factors eye drops to treat secondary ocular surface disorders in patients with glaucoma","volume":"11","author":"Sanchez-Avila","year":"2018","journal-title":"Int Med Case Rep J"},{"key":"10.1016\/j.jtos.2022.04.007_bib23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.exer.2013.07.007","article-title":"Plasma rich in growth factors (PRGF-Endoret) stimulates corneal wound healing and reduces haze formation after PRK surgery","volume":"115","author":"Anitua","year":"2013","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2022.04.007_bib24","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000024139","article-title":"Plasma rich in growth factors versus Mitomycin C in photorefractive keratectomy","volume":"100","author":"Sanchez-Avila","year":"2021","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.jtos.2022.04.007_bib25","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/ICO.0000000000000109","article-title":"Corneal wound healing promoted by 3 blood derivatives: an in vitro and in vivo comparative study","volume":"33","author":"Freire","year":"2014","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2022.04.007_bib26","doi-asserted-by":"crossref","first-page":"e693","DOI":"10.1111\/aos.13371","article-title":"Serum from plasma rich in growth factors regenerates rabbit corneas by promoting cell proliferation, migration, differentiation, adhesion and limbal stemness","volume":"95","author":"Etxebarria","year":"2017","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.jtos.2022.04.007_bib27","first-page":"571","article-title":"Diagnosis and management of neurotrophic keratitis","volume":"8","author":"Sacchetti","year":"2014","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2022.04.007_bib28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S1542-0124(12)70053-8","article-title":"Development and validation of a short global dry eye symptom index","volume":"5","author":"Schaumberg","year":"2007","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2022.04.007_bib29","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jtos.2021.09.003","article-title":"Combined therapy of ocular surface disease with plasma rich in growth factors and scleral contact lenses","volume":"23","author":"Wang","year":"2022","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2022.04.007_bib30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jtos.2021.08.003","article-title":"Concurrent ocular pain in patients with neurotrophic keratopathy","volume":"22","author":"Yavuz Saricay","year":"2021","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2022.04.007_bib31","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1089\/ten.tea.2012.0557","article-title":"Platelet-rich plasma exerts antinociceptive activity by a peripheral endocannabinoid-related mechanism","volume":"19","author":"Descalzi","year":"2013","journal-title":"Tissue Eng"},{"key":"10.1016\/j.jtos.2022.04.007_bib32","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/jcp.22274","article-title":"Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: mechanisms of NF-kappaB inhibition via HGF","volume":"225","author":"Bendinelli","year":"2010","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.jtos.2022.04.007_bib33","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.ophtha.2006.10.044","article-title":"Use of autologous platelet-rich plasma in the treatment of dormant corneal ulcers","volume":"114","author":"Alio","year":"2007","journal-title":"Ophthalmol."},{"key":"10.1016\/j.jtos.2022.04.007_bib34","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s40123-017-0100-z","article-title":"Treatment of dry eye disease with autologous platelet-rich plasma: a prospective, interventional, non-randomized study","volume":"6","author":"Alio","year":"2017","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.jtos.2022.04.007_bib35","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1160\/TH03-07-0440","article-title":"Autologous platelets as a source of proteins for healing and tissue regeneration","volume":"91","author":"Anitua","year":"2004","journal-title":"Thromb Haemostasis"},{"key":"10.1016\/j.jtos.2022.04.007_bib36","doi-asserted-by":"crossref","first-page":"6066","DOI":"10.1167\/iovs.11-7302","article-title":"Plasma rich in growth factors (PRGF-Endoret) stimulates proliferation and migration of primary keratocytes and conjunctival fibroblasts and inhibits and reverts TGF-beta1-Induced myodifferentiation","volume":"52","author":"Anitua","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2022.04.007_bib37","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1097\/ICO.0b013e3181a2a7f6","article-title":"Autologous serum 50% eyedrops in the treatment of persistent corneal epithelial defects","volume":"28","author":"Jeng","year":"2009","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2022.04.007_bib38","first-page":"145","article-title":"Targeting growth factor supply in keratopathy treatment: comparison between maternal peripheral blood and cord blood as sources for the preparation of topical eye drops","volume":"14","author":"Versura","year":"2016","journal-title":"Blood Transfus."},{"key":"10.1016\/j.jtos.2022.04.007_bib39","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.ophtha.2006.12.014","article-title":"Application of umbilical cord serum eyedrops for the treatment of neurotrophic keratitis","volume":"114","author":"Yoon","year":"2007","journal-title":"Ophthalmol."},{"key":"10.1016\/j.jtos.2022.04.007_bib40","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jtos.2020.09.007","article-title":"The molecular basis of neurotrophic keratopathy: diagnostic and therapeutic implications. A review","volume":"19","author":"Ruiz-Lozano","year":"2021","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2022.04.007_bib41","first-page":"351","article-title":"Ocular graft versus host disease following allogeneic stem cell transplantation: a review of current knowledge and recommendations","volume":"8","author":"Nassiri","year":"2013","journal-title":"J Ophthalmic Vis Res"},{"key":"10.1016\/j.jtos.2022.04.007_bib42","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jtos.2019.12.005","article-title":"Tear cytokine levels in the diagnosis and severity assessment of ocular chronic graft-versus-host disease(GVHD)","volume":"18","author":"Hu","year":"2020","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2022.04.007_bib43","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s40135-020-00227-z","article-title":"Ocular graft-versus-host disease topic review","volume":"8","author":"Hazem","year":"2020","journal-title":"Curr. Ophthalmol."}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012422000350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012422000350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:45:51Z","timestamp":1761540351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012422000350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":43,"alternative-id":["S1542012422000350"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2022.04.007","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A multicenter report of the use of plasma rich in growth factors (PRGF) for the treatment of patients with ocular surface diseases in North America","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2022.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}